HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Radhe Mohan Selected Research

Prostatic Neoplasms (Prostate Cancer)

10/2012Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06.
11/2010Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model.
5/2008Can megavoltage computed tomography reduce proton range uncertainties in treatment plans for patients with large metal implants?
5/2008Daily bone alignment with limited repeat CT correction rivals daily ultrasound alignment for prostate radiotherapy.
11/2007Is a 3-mm intrafractional margin sufficient for daily image-guided intensity-modulated radiation therapy of prostate cancer?
8/2007Changes in the pelvic anatomy after an IMRT treatment fraction of prostate cancer.
8/2007Treatment-planning study of prostate cancer intensity-modulated radiotherapy with a Varian Clinac operated without a flattening filter.
3/2007Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer.
2/2007Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment.
11/2006Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Radhe Mohan Research Topics

Disease

83Neoplasms (Cancer)
03/2024 - 07/2002
61Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 03/2004
21Lung Neoplasms (Lung Cancer)
07/2021 - 06/2006
19Esophageal Neoplasms (Esophageal Cancer)
03/2024 - 12/2005
18Lymphopenia (Lymphocytopenia)
08/2023 - 01/2018
18Prostatic Neoplasms (Prostate Cancer)
10/2012 - 04/2004
14Head and Neck Neoplasms (Head and Neck Cancer)
02/2022 - 01/2002
11Radiation Pneumonitis
01/2019 - 07/2010
7Esophagitis
04/2022 - 09/2006
5Neoplasm Metastasis (Metastasis)
10/2021 - 11/2003
5Brain Neoplasms (Brain Tumor)
07/2021 - 08/2013
5Second Primary Neoplasms (Neoplasms, Second)
10/2018 - 03/2009
5Pneumonia (Pneumonitis)
01/2018 - 05/2007
4Oropharyngeal Neoplasms
01/2017 - 08/2006
3Hepatocellular Carcinoma (Hepatoma)
08/2023 - 09/2008
3Carcinoma (Carcinomatosis)
01/2019 - 12/2003
3Hemorrhage
07/2005 - 06/2004
2Melanoma (Melanoma, Malignant)
06/2022 - 01/2017
2Chordoma
06/2022 - 01/2017
2Chondrosarcoma
06/2022 - 01/2017
2Necrosis
02/2022 - 01/2018
2Lymphoma (Lymphomas)
07/2021 - 10/2018
2Pericardial Effusion
01/2021 - 03/2008
2Ependymoma
04/2020 - 12/2016
2Weight Loss (Weight Reduction)
01/2016 - 07/2004
2Squamous Cell Carcinoma of Head and Neck
10/2004 - 06/2003
2Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2002 - 01/2002
1Cardiotoxicity
11/2021
1Anus Neoplasms (Anal Cancer)
10/2021
1Glioblastoma (Glioblastoma Multiforme)
01/2021
1Thrombosis (Thrombus)
01/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2021
1Dermatitis
01/2020
1Radiodermatitis
01/2020
1Pathologic Complete Response
01/2018
1Infratentorial Neoplasms (Posterior Fossa Tumors)
01/2018
1Lung Injury
01/2018
1Mediastinal Diseases
01/2018
1Hypoxia (Hypoxemia)
01/2018
1Liver Neoplasms (Liver Cancer)
11/2017
1Glioma (Gliomas)
01/2017
1Hypothyroidism
12/2016
1Deglutition Disorders (Dysphagia)
12/2016
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2016
1Pain (Aches)
01/2016
1Fatigue
01/2016
1Hypertension (High Blood Pressure)
11/2010

Drug/Important Bio-Agent (IBA)

45Protons (Proton)IBA
03/2024 - 07/2006
6Biomarkers (Surrogate Marker)IBA
11/2021 - 04/2013
2HeliumIBA
01/2022 - 12/2020
2IonsIBA
12/2020 - 01/2018
2CarbonIBA
12/2020 - 01/2018
2DNA (Deoxyribonucleic Acid)IBA
04/2020 - 12/2019
1Immune Checkpoint InhibitorsIBA
01/2023
1durvalumabIBA
09/2022
1CalciumIBA
01/2022
1Troponin T (Troponin T1)IBA
11/2021
1Oxygen (Dioxygen)IBA
12/2020
1lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
12/2019
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2018
1CobaltIBA
01/2018
1Tyr sulfate(1)- enkephalinamide-Leu (LETS)IBA
11/2017
1ORALIT (ORS)IBA
01/2016
1adenovirus receptorIBA
12/2013
1CateninsIBA
12/2013
1Paclitaxel (Taxol)FDA LinkGeneric
12/2013
1Indicators and Reagents (Reagents)IBA
11/2013
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2013
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2013
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2013
1Coxsackie and Adenovirus Receptor-Like Membrane ProteinIBA
11/2012
1Telomerase (Telomerase Reverse Transcriptase)IBA
11/2012
1matrigelIBA
11/2012
1Small Interfering RNA (siRNA)IBA
11/2012
1HSP27 Heat-Shock ProteinsIBA
10/2012
1V 70 (V70)IBA
09/2012
1Carbon MonoxideIBA
08/2012
1Hormones (Hormone)IBA
11/2010

Therapy/Procedure

114Radiotherapy
03/2024 - 07/2002
71Proton Therapy
03/2024 - 02/2007
37Therapeutics
08/2023 - 10/2004
23Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
06/2023 - 01/2002
17Drug Therapy (Chemotherapy)
04/2022 - 07/2002
11Conformal Radiotherapy
07/2012 - 03/2004
10Chemoradiotherapy
03/2024 - 11/2006
6Aftercare (After-Treatment)
07/2021 - 03/2009
4Immunotherapy
08/2023 - 01/2018
3Neoadjuvant Therapy
03/2024 - 01/2018
3Patient Positioning
07/2008 - 12/2007
3Particle Accelerators
05/2008 - 11/2003
2Drug Tapering
01/2022 - 07/2002
2Enteral Nutrition (Feeding, Tube)
12/2016 - 01/2016
2Craniospinal Irradiation
04/2009 - 04/2009
2Hip Prosthesis
05/2008 - 01/2003
2Induction Chemotherapy
03/2008 - 12/2003
2Image-Guided Radiotherapy
02/2008 - 07/2005
1Esophagectomy
03/2024
1Colostomy
10/2021
1Heavy Ion Radiotherapy
01/2017
1Defibrillators (Defibrillator)
11/2013